Trial intelligence / Profile preview

Tongnao Rongshuan Capsule in Recovery-Phase Ischemic Stroke

CTR20130271Phase 2Completed

Sponsor
Zhouliang Mingkang Biopharmaceutical
Start
Mar 2014
Modality
Therapeutic Enzymes → Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 2 trial of staphylokinase in brain infarction, ischemic stroke, sponsored by Zhouliang Mingkang Biopharmaceutical. Started Mar 2014; status: completed.

02

Drugs

staphylokinase
03

Conditions

brain infarctionischemic stroke

Beyond the preview

Go deeper on CTR20130271.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20130271.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call